Neurizon Therapeutics Ltd NUZTF
$0.05
Last Updated: Jun 29, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
NUZTF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Neurizon Therapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Neurizon Therapeutics Ltd. Stock Analysis NUZTF
United States Health Care Nano Cap Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-10-05. The firm is engaged in advancing treatments for neurodegenerative diseases. The company is developing its lead drug candidate, NUZ-001, for the treatment of Amyotrophic Lateral Sclerosis (ALS), which is the common form of motor neurone disease. ALS treatments for patients while exploring the potential of NUZ-001 for broader neurodegenerative applications. ALS is a devastating neurodegenerative condition that primarily affects nerve cells that control voluntary muscles. Through international collaborations and rigorous clinical programs, it is focused on creating new horizons for patients and families impacted by complex neural disorders.
Neurizon Therapeutics Ltd (NUZTF) Chart
Financial Metrics & Statements of Neurizon Therapeutics Ltd (NUZTF)
FAQ's for Neurizon Therapeutics Ltd (NUZTF)
- As of August 2026, Neurizon Therapeutics Ltd NUZTF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neurizon Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Neurizon Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Neurizon Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Neurizon Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Neurizon Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Neurizon Therapeutics Ltd (NUZTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
